Context Therapeutics CNTX
NASDAQ CNTX
$0.24 +0.00 (+1.57%)
At close: Oct 23, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Return on Sales [ROS] (2021 - 2024)

Updated

Analysis

Context Therapeutics (CNTX) Return on Sales [ROS] (2021 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 Context Therapeutics 22.66 Mn -217.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -1,503.71%
Jun 30, 2024 -367.62%
Mar 31, 2024 -2,509.67%
Dec 31, 2023 -3,085.28%
Sep 30, 2023 -2,127.98%
Jun 30, 2023 -1,804.58%
Mar 31, 2023 -1,875.04%
Dec 31, 2022 -1,184.14%
Sep 30, 2022 -2,105.69%
Jun 30, 2022 -18,819.55%
Mar 31, 2022 -58,713.54%
Dec 31, 2021 -981,556.83%
API Access

Context Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CNTX&period=max&api_key=YOUR_API_KEY